NCT00000319
Completed
Phase 2
Buprenorphine Maintenance Dose Schedule and Treatment Setting
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Opioid-Related Disorders
- Sponsor
- Yale University
- Locations
- 1
- Primary Endpoint
- Withdrawal symptoms
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this study is to evaluate the efficacy of treating opioid-dependent individuals with buprenorphine on a thrice-weekly schedule compared to daily dosing.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- Not provided
Outcomes
Primary Outcomes
Withdrawal symptoms
Social and psychological functioning
Opioid and cocaine use
AIDS risk behavior
Depression
Opiate withdrawal symptoms
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary CareHeroin DependenceOpioid-Related DisordersSubstance Abuse, IntravenousNCT00471042New York State Psychiatric Institute30
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 2Opioid-Related DisordersNCT00000203Yale University
Completed
Phase 1
Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-ReleaseOpiate AddictionNCT00367302National Development and Research Institutes, Inc.116
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 1Opioid-Related DisordersNCT00000202Yale University
Completed
Phase 2
Buprenorphine Maintenance for Opioid Addicts - 3Opioid-Related DisordersNCT00000204Yale University